ATA gearing up to launch accreditation program

Laura Pedulli | | Health Exec | Precision Medicine

The American Telemedicine Association is looking to launch an accreditation program this fall for primary care and urgent care.

The association currently is seeking comment on a draft document that outlines parameters of a telehealth program. Specifically, the guidelines recommend that telemedicine in primary care settings should focus on less acute conditions, or should be used for simple or routine follow-up for patients with chronic conditions. For urgent care, telemedicine is appropriate for allergies and asthma, influenza, low back pain and upper respiratory infections.

Comments on the draft guidelines, available here, are due by June 12.

 

Laura Pedulli

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.